Calumet, Inc. /DE
No SEC Form 4 filings for $CLMT in the last 30 days.
Calumet (CLMT) shares fell about 6% on Friday after its Q2 earnings showed a surprise net loss. Revenue rose to just under $1.45B, up about 41% YoY, but adjusted net loss was $95.9M, or $1.09/share, versus a year-ago deficit of $147.9M. Analysts expected profit of $0.17/share. Long-term debt exceeded $2.2B.
Calumet, Inc. (CLMT) reported Q2 net loss of $95.9 million, or $1.09 per share, versus $147.9 million, or $1.70 per share, a year earlier. Net sales rose to $1,445.1 million from $1,026.6 million. The company cited higher revenue and a smaller operating loss, plus derivative unrealized gains and RIN-related non-cash expense. CLMT traded at $40.70 premarket, down 2.82% on Nasdaq.
Calumet (NASDAQ:CLMT) reported Q2 CY2026 results. Revenue rose 40.8% year on year to $1.45 billion, beating Wall Street estimates by 32% (according to the article). Adjusted EBITDA exceeded consensus by 78.2%, with margin rising to 12.1%. Free cash flow was $99.35 million, turning positive after a year-ago loss.
Over the past 7 days, alphai's AI scored 5 news stories mentioning CLMT (Calumet, Inc. /DE). Coverage has been balanced: 1 bullish, 3 neutral, and 1 bearish.
Recent CLMT coverage spans earnings, market movers and corporate actions.
The earnings print is a negative earnings surprise, with the loss attributed to RIN accounting, fuel hedging, and debt servicing, while leverage remains a key risk.
Results show improving losses year over year, but large non-cash RINs expense and derivative unrealized items remain key swing factors.
Results beat on revenue and adjusted EBITDA, but free cash flow remains volatile and historically negative, limiting conviction.
The filing combines weaker GAAP earnings with stronger operating cash earnings metrics and active deleveraging, which can shift near-term credit and equity risk perception.
This is an earnings preview with limited new fundamentals, but it frames consensus expectations and recent estimate behavior ahead of the print.
alphai scores every news story that mentions CLMT with an AI model for sentiment and relevance, and aggregates insider trades from Calumet, Inc. /DE's SEC EDGAR Form 4 filings. Figures refresh continuously.
Calumet (CLMT) shares fell about 6% on Friday after its Q2 earnings showed a surprise net loss. Revenue rose to just under $1.45B, up about 41% YoY, but adjusted net loss was $95.9M, or $1.09/share, versus a year-ago deficit of $147.9M. Analysts expected profit of $0.17/share. Long-term debt exceeded $2.2B.
4 min readCalumet, Inc. (CLMT) reported Q2 net loss of $95.9 million, or $1.09 per share, versus $147.9 million, or $1.70 per share, a year earlier. Net sales rose to $1,445.1 million from $1,026.6 million. The company cited higher revenue and a smaller operating loss, plus derivative unrealized gains and RIN-related non-cash expense. CLMT traded at $40.70 premarket, down 2.82% on Nasdaq.
2 min readCalumet (NASDAQ:CLMT) reported Q2 CY2026 results. Revenue rose 40.8% year on year to $1.45 billion, beating Wall Street estimates by 32% (according to the article). Adjusted EBITDA exceeded consensus by 78.2%, with margin rising to 12.1%. Free cash flow was $99.35 million, turning positive after a year-ago loss.
6 min readCalumet, Inc. /DE (CLMT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 clmt-20260630xex991.htm EX-99.1 Document Exhibit 99.1 Calumet Reports Second Quarter 2026 Results • Second Quarter 2026 net loss of $(95.9) million, or basic earnings per common share of $(1.09), driven by non-cash RINs and other mark-to-market items • Second Quarter 20
6 min readCalumet (CLMT) is set to report Q2 results. Last quarter, it posted revenue of $1.03 billion, up 3.6% year on year, beating revenue expectations, and it beat EPS but missed EBITDA. For Q2, analysts expect revenue growth of 6.6% year on year. CLMT is up 4.2% over the past month, with an average price target of $39.60 versus $40.42.
3 min readInvesting.com reports Calumet Inc. (CLMT) shares may move about 7% around earnings on Aug. 7 before market open, based on Bloomberg options data. The piece notes that in 4 of the past 8 earnings, the stock’s move exceeded options-implied expectations. Historical examples are cited for 2024-2026.
2 min readMarkets swung as AI stocks tried to rebound and Nasdaq stayed under pressure. Micron rose 12.2% then fell 7% after the week’s selloff; Brent crude broke $100 then ended at $96.78, down 3.9%. Alphabet shares fell 7.1% after raising 2026 capex to $195–$205B. Tesla dropped 14.5%. 10-year yields eased to 4.68%.
7 min readCalumet (CLMT) shares rose more than 4% after the company said two wholly owned subsidiaries will redeem $100 million of senior notes due 2028, paying about 102.4% of par. Calumet also noted it reduced borrowings on its revolving credit facility in Q2, as part of a deleveraging plan.
4 min readCalumet, Inc. (NASDAQ: CLMT) said its subsidiaries will redeem all $100 million of 9.75% senior notes due 2028 on July 15, 2026. The cash redemption price is 102.438% of principal plus accrued interest. Calumet cited balance-sheet strengthening and reduced interest expense.
2 min readCalumet Director Daniel Sajkowski sold 3,310 shares of the company's stock on April 1st for a total of $114,062.60, reducing his stake by 3.88%. This transaction comes as Calumet has shown strong Q4 earnings, beating analyst expectations, and has seen its stock price rally towards a 52-week high with increased analyst attention, despite facing some near-term operational risks from unplanned maintenance.
2 min read
